reports
- ABGSC Oil & Oil Services Research
- John Olaisen
- ABGSC Energy Research
- John Olaisen
- Lars Trongaard Brattli
- Njål Kleiven
- Oliver Dunvold
BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Ob...
BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits observed in combination with incretin therapy Data support development of next-generation APJ agonists for obesity and key comorbidities EMERYVILLE, Calif., June 21, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biotechnology company devel...
Aduro Clean Technologies annonce la clôture de l’option de surallocati...
Aduro Clean Technologies annonce la clôture de l’option de surallocation du souscripteur dans le cadre d’une offre publique LONDON, Ontario, 21 juin 2025 (GLOBE NEWSWIRE) -- ci-après « Aduro » ou la « Société » (Nasdaq : ADUR, CSE :ACT (FSE : 9D5), une entreprise de technologie propre qui exploite la puissance de la chimie pour recycler les matières premières de moindre valeur comme les déchets plastiques, le bitume lourd ou les huiles renouvelables en ressources adaptées au XXIe siècle, a annoncé aujourd’hui l’émission de 142 180 actions ordinaires supplémentaires et de bons de souscrip...
Aduro Clean Technologies gibt Abschluss der Mehrzuteilungsoption des K...
Aduro Clean Technologies gibt Abschluss der Mehrzuteilungsoption des Konsortialbankers im Rahmen der Emission bekannt LONDON, Ontario, June 21, 2025 (GLOBE NEWSWIRE) -- („Aduro” oder das „Unternehmen”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Unternehmen im Bereich sauberer Technologien, das die Kraft der Chemie nutzt, um minderwertige Rohstoffe wie Kunststoffabfälle, schweres Bitumen und erneuerbare Öle in Ressourcen für das 21. Jahrhundert umzuwandeln, hat heute bekanntgegeben, dass es gemäß der vollständigen Ausübung der Bezugsrechte durch D. Boral Capital LLC weitere 142.180 Stammak...
Perspective Therapeutics Presents at the Society of Nuclear Medicine a...
Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting SEATTLE, June 21, 2025 (GLOBE NEWSWIRE) -- (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, announced two presentations on its assets being delivered at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting taking place June 21-24, 2025 in New Orleans, Louisiana. Lead authorAbstract TitlePresentation DetailsStephen Graves[212Pb]Pb-VMT-α-NET dos...
Perspective Therapeutics Commences Recruitment for [212Pb]VMT-α-NET in...
Perspective Therapeutics Commences Recruitment for [212Pb]VMT-α-NET in the Third Dose Escalation Cohort of its Ongoing Phase 1/2a Clinical Trial [212Pb]VMT-α-NET Phase 1/2a study is advancing into Cohort 3 with a fixed administered dose that is up to 20% higher (6 mCi) than the dose administered to patients in Cohort 2Dosimetry sub-study analysis presented at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2025 Annual Meeting to advance utility of dosimetry in clinical development when considered with clinical dataOn track to submit further clinical updates to scientific congres...
Stingray Group Inc: 1 director
A director at Stingray Group Inc sold 1,012,540 shares at 10.000CAD and the significance rating of the trade was 84/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Icarus Capital Corp: 1 director
A director at Icarus Capital Corp bought 400,000 shares at 0.100CAD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Maps SpA: 1 director
A director at Maps SpA sold 75,000 shares at 3.440EUR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...
Everyday People Financial Corp: 2 directors
Two Directors at Everyday People Financial Corp bought/sold 1,110,000 shares at between 0.730CAD and 0.820CAD. The significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the compan...
D2L Inc: 1 director
A director at D2L Inc sold/sold after exercising options 35,000 shares at 0.000CAD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
Privi Speciality Chemicals Ltd: 1 director
A director at Privi Speciality Chemicals Ltd sold 950,000 shares at 2,055.000INR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
Oracle Corp: 2 directors
Two Directors at Oracle Corp sold/sold after exercising options 23,169 shares at between 213.490USD and 214.099USD. The significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the c...
Peyto Exploration & Development Corp: 2 directors
A director at Peyto Exploration & Development Corp sold 200,000 shares at 20.545CAD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...
Gogo Inc: 1 director
A director at Gogo Inc sold 107,136 shares at 15.000USD and the significance rating of the trade was 96/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...
Super Micro Computer Inc: 1 director
A director at Super Micro Computer Inc sold 300,000 shares at 45.000USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Shanghai Sanyou Medical Co Ltd: 1 director
A director at Shanghai Sanyou Medical Co Ltd sold 2,600,000 shares at 15.840CNY and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Shenzhen Kinwong Electronic Co Ltd: 2 directors
Two Directors at Shenzhen Kinwong Electronic Co Ltd sold 298,800 shares at between 32.480CNY and 32.600CNY. The significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.